Modification of (i) Acquisition Agreement and (ii) Associated Seller’s Acquisition NotesAcquisition Agreement • June 18th, 2020 • Cannabis Global, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledJune 18th, 2020 Company Industry JurisdictionThis Modification of Acquisition Agreement (“Modification Agreement”) is entered into by and between Cannabis Global, Inc., a Nevada corporation formerly known as MCTC Holdings, Inc. (hereafter referred to as “CGI”) and Lelantos Biotech., a Wyoming corporation, including without limitation its shareholders, owners, affiliates, control persons, successors and assigns, including, but not limited to, Mt. Fire, LLC, a Nevada limited liability company (“Mt. Fire”), Ma Helen M. Am Is, Inc., a Wyoming Corporation (“Helen M.”), New Horizons Laboratory Services, Inc., a Wyoming Corporation (“New Horizons”), and East West Pharma Group, Inc., a Wyoming Corporation (“East – West”) (or collectively, “Lelantos”). CGI and Lelantos may be referred to individually as a “Party” or collectively as the “Parties.”
ACQUISITION AGREEMENT DATED AS OF FEBRUARY 4, 2020 BY AND BETWEEN MCTC HOLDINGS, INC. AND LELANTOS BIOTECH, INC.Acquisition Agreement • June 5th, 2020 • Cannabis Global, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJune 5th, 2020 Company Industry JurisdictionTHIS ACQUISITION AGREEMENT (“Agreement”) is entered into as of February 12, 2020 (the “Effective Date”), by and between MCTC Holdings, Inc., a Delaware corporation (“MCTC” or “Buyer”), Lelantos Biotech, Inc., a privately held Wyoming Corporation (“Lelantos” or “Seller”), and the Owners of Lelantos (the “Owners”).